Intranasal Oxytocin to Treat Mental Disorders: A Meta-Analysis of Randomized Controlled Trials

Intranasal oxytocin has received growing attention for its potential to improve the treatment of mental disorders. The current systematic review is the first to meta-analyze clinical outcomes across psychiatric diagnoses since 2013. Overall efficacy was null; meta-regressions will uncover key individual and contextual factors influencing oxytocin’s effects in clinical populations.